Corient Private Wealth’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $647K | Buy |
+14,985
| New | +$647K | ﹤0.01% | 1657 |
|
|
2025
Q1 | – | Sell |
-19,259
| Closed | -$967 | – | 2289 |
|
|
2024
Q4 | $967 | Sell |
19,259
-104
| -0.5% | -$5 | ﹤0.01% | 2337 |
|
|
2024
Q3 | $493K | Buy |
19,363
+120
| +0.6% | +$3.06K | ﹤0.01% | 1712 |
|
|
2024
Q2 | $487K | Hold |
19,243
| – | – | ﹤0.01% | 1645 |
|
|
2024
Q1 | $595K | Hold |
19,243
| – | – | ﹤0.01% | 1542 |
|
|
2023
Q4 | $777K | Hold |
19,243
| – | – | ﹤0.01% | 1390 |
|
|
2023
Q3 | $507K | Sell |
19,243
-16,000
| -45% | -$422K | ﹤0.01% | 1487 |
|
|
2023
Q2 | $606K | Hold |
35,243
| – | – | ﹤0.01% | 1353 |
|
|
2023
Q1 | $584K | Buy |
35,243
+2,000
| +6% | +$33.2K | ﹤0.01% | 1303 |
|
|
2022
Q4 | $253K | Buy |
+33,243
| New | +$253K | ﹤0.01% | 1397 |
|